Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial

Nomathemba ChandiwanaC KrugerH JohnstoneM ChughlayC JuYengiwe DinekaE et alWillem Venter2024-05-082024-05-08WOS2352-3964https://hdl.handle.net/10539/38431Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trialJournal Article